Molecular genetics of colorectal cancer;Genética molecular del cáncer colorrectal

Revista Espanola de Enfermedades Digestivas

Volumn 96, Issue 1, 2004, Pages 48-59

  Cruz Bustillo Clarens, Diana ^a,b  

^a INSTITUTO DE GASTROENTEROLOGÍA   (Cuba)

^b NONE   (Cuba)

Author keywords

Caretakers and gatekeepers; Colorectal cancer; Colorectal carcinogenesis; Germinal mutation; Microsatellite instability; Sporadic mutation; Tumor suppressor genes

Indexed keywords

APC PROTEIN; BETA CATENIN; ONCOPROTEIN; SURVIVIN; TUMOR SUPPRESSOR PROTEIN; UVOMORULIN; WNT PROTEIN;

ADENOMATOUS POLYP; CANCER CLASSIFICATION; CANCER STAGING; CANCER SUSCEPTIBILITY; COLON CARCINOGENESIS; COLON POLYPOSIS; COLORECTAL CANCER; CROHN DISEASE; FAMILIAL CANCER; GENE MUTATION; HEREDITY; HUMAN; MOLECULAR GENETICS; ONCOGENE; PATHOGENESIS; PEUTZ JEGHERS SYNDROME; REVIEW; TUMOR SUPPRESSOR GENE; ULCERATIVE COLITIS;

EID: 1542291169     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: 10.4321/S1130-01082004000100007     Document Type: Review

References (51)

1. Burt RW. Colon Cancer Screening. Gastroenterology 2000; 119: 837-53.
2. National Cancer Institute. Cancer genetics Overview. Available at: http://www.cancer.gov/cancerinfo/pdq/genetics/ overview.html Date last modified: 06/2002.
3. Burt RW, DiSario JA, Cannon-Albright LA. Genetics of colon cancer: Impact of inheritance on colon cancer risk. Annu Rev Med 1995; 46: 371-9.
4. Potter, JD. Colorectal cancer: Molecules and population. J Nat Cancer Inst 1999; 91: 916-32.
5. Lynch HT, Lynch JF. Genetics of colorectal cancer. Digestion 1998; 59: 481-92.
6. Online Mendelian Inheritance in Man, OMIM (TM). John Hopkins University, Baltimore, MD. MIM Number: 175100: January 29, 2003: World Wide Web URL: http://www.ncbi.nlm.nih.gov/omim/.
7. Wu JS, Paul P, Mc Gannon EA, Church JM. APC genotype, polyp number and surgical options in familial adenomatous polyposis. Ann Surg 1998; 227: 57-62.
8. Burt RW, Jacoby RF. Polyposis syndromes. In: Yamalda T, ed. Text book of gastroenterology. 3rd. ed. Philadelphia: Lippincott Raven, 1999. p. 1995-2022.
9. Guillem JG, Smith AJ, Culle J, Ruo L. Gastrointestinal polyposis syndromes. Curr Prob Surg 1999; 36: 219-323.
10. King JE, Dozois RR, Lindor NM, Alquist DA. Care of patients and their families with familial adenomatous polyposis. May Clin Proc 2000; 75: 57-67.
11. Vasen RFA, Mecklin JP, Meera-Khan P, Lynch HT. International Collaborative Group on hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Dis Colon Rectum 1991; 34: 424.
12. Rodríguez-Bigas MA, Boland CR, Hamilton SR, Henson DE, Jass JR, Khan PM, et al. A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 1997; 89: 1758-62.
13. N Katballe, M Christensen, F P Wikman, T F Ørntoft, S Laurberg. Frequency of hereditary non-polyposis colorectal cancer in Danish colorectal cancer patients. Gut 2002; 50: 43-51.
14. Hahn M, Saeger HD, Schackert HK. Hereditary colorectal cancer: clinical consequences of predictive molecular testing. Int J Colorectal Dis 1999; 14: 184-93.
15. Mecklin JP, Peltomaki P. Genetic changes associated with colon tumor development. Ann Chiru Gynaecol 2000; 89: 211-5.
16. Carethers JM. The cellular and molecular pathogenesis of colorectal cancer. Gastroent Clinics North Am 1996; 25: 737-54.
17. Kinzler KW, Vogelstein B. Cancer susceptibility genes. Gatekeepers and Caretakers. Nature 1997; 386: 761-3.
18. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, et al. Identification and characterization of the familial adenomatous polyposis coli. Cell 1991; 66: 589-600.
19. Nishisho I, Nakamura Y, Miyoshi Y, Miki Y, Ando H, Horii A, et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991; 253: 665-9.
20. Thliveris A, Albertsen H, Tuohy T, Carlson M, Groden J, Joslyn G, et al. Long-range physical map and deletion characterization of the 1100-kb Not I restriction fragment harboring the APC gene. Genomics 1996; 34: 268-70.
21. Horii A, Nakatsuru S, Ichii S, Nagase H, Nakamura Y. Multiple forms of the APC gene transcripts and their tissue-specific expression. Hum Mol Genet 1993; 2: 283-7.
22. Beroud C, Soussi T. APC gene: database of germline and somatic mutations in human tumors and cell lines. Nucleic Acids Res 1996; 24: 121-4.
23. Fearnhead NS, Britton MP, Bodmer WF. The ABC of APC. Hum Mol Genet 2001; 10: 721-33.
24. Su LK, Jonson KA, Smith KJ, Hill DE, Vogelstein B, Kinzler KW. Association between wild-type and mutant APC gene products. Cancer Res 1993; 53: 2728-31.
25. Huelsken J, Birchmeier W. New aspects of Wnt signaling pathways in higher vertebrates. Curr Opin Genet Dev 2001; 11: 547-53.
26. Fodde R. The multiple functions of tumour suppressors: it's all in APC. Nat Cell Biol 2003.
27. McEwen DG. Wnt signaling: The naked truth? Curr Biol 2001; 11: R524-R526.
28. van Es JH, Giles RH, Clevers HC. The many faces of the tumor supressor gene APC. Exp Cell Res 2001; 264: 126-34.
29. Korinek V, Barker N, Moerer P, van Donselaar E, Huls G, Peters PJ, et al. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet 1998; 19: 379-83.
30. Fuchs E, Segre JA. Stem cells: a new lease on life. Cell 2000; 100: 143-55.
31. Lustig B, Behrens J. The Wnt signaling pathway and its role in tumor development. J Cancer Res Clin Oncol 2003; 129: 199-221.
32. Orford K, Crockett C, Jensen JP, Weissman AM, Byers SW. Serine phosphorylation-regulated ubiquitination and degradation of beta-catenin. J Biol Chem 1997; 272: 24735-8.
33. Polakis P. The oncogenic activation of beta-catenin. Curr Opin Genet Dev 1999; 9: 15-21.
34. Kobayashi M, Honma T, Matsuda Y, Suzuki Y, Narisawa R, Ajioka Y, et al. Nuclear translocation of beta-catenin in colorectal cancer. Br J Cancer 2000; 82: 1689-93.
35. Rubinfeld B, Albert I, Porfiri, E, Munemitsu S, Polakis P. Loss of beta-catenin regulacion by the APC tumor suppressor protein correlates with loss of structure due to common somatic mutations of the gene. Cancer Res 1997; 57: 4624-30.
36. Roose J, Clevers H. TCF transcription factors: molecular switches in carcinogenesis. Biochim Biophys Acta 1999; 1424: M23-M37.
37. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, et al. Identification of c-MYC as a target of the APC pathway. Science 1998; 281: 1509-12.
38. Tetsu O, McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999; 398: 422-6.
39. Gumbiner BM. Signal transduction of beta-catenin. Curr Opin Cell Biol 1995; 7: 634-40.
40. Kintner C. Regulation of embryonic cell adhesion by the cadherin cytoplasmic domain. Cell 1992; 69: 225-36.
41. Mahmoud NN, Boolbol SK, Bilinski RT, Martucci C, Chadburn A, Bertagnolli MM. Apc gene mutation is associated with a dominant-negative effect upon intestinal cell migration. Cancer Res 1997; 57: 5045-50.
42. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997; 3: 917-21.
43. Bao R, Connolly DC, Murphy M, Green J, Weinstein JK, Pisarcik DA, et al. Activation of cancer-specific gene expression by the Survivin promoter. J Natl Cancer Inst 2002; 94: 522-8.
44. Altieri DC, Marchisio PC, Marchisio C. Survivin apoptosis: an interloper between cell death and cell proliferation in cancer. Lab Investg 1999; 79: 1327-33.
45. Altieri D. The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol Med 2001; 7 (12): 542-7.
46. Zhang T, Otevrel T, Gao Z, Gao Zh, Ehrlich SM, Fields JZ, et al. Evidence that TPC regulates Survivin expression: A possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res 2001; 62: 8664-7.
47. Online Mendelian Inheritance in Man, OMIM (TM). John Hopkins University, Baltimore, MD. MIM Number: 120435. November 16, 2000: World Wide Web URL: http://www.ncbi.nlm.nih.gov/omim/.
48. Levitt NC, Hickson ID. Caretaker tumour suppressor genes that defend genome integrity. Trends in Molecular Medicine 2002; 8: 179-86.
49. Kuismanen SA, Holmberg MT, Salovaara R, de la Chapelle A, Peltomaki P. Genetic and epigenetic modification of MLH1 accounts for a major share of microsatellite-unstable colorectal cancers. Am J Pathol 2000; 156: 1773-9.
50. Bhattacharyya NP, Skandalis A, Ganesh A, Groden J, Meuth M. Mutator phenotypes in human colorectal carcinoma cell lines. Proc Natl Acad Sci USA 1994; 91: 6319-23.
51. Hardy RG, Meltzer SJ, Jankowski JA. ABC of colorectal cancer. Molecular basis for risk factors. BMJ 2000; 321: 886-9.